Novo Nordisk at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Novo Nordisk brings 6 presentations to SCOPE 2027 in Orlando. Its sessions cover study design, the value of site training and building a culture of risk-based quality management. Distinctive topics include data tokenization for real-world evidence and DECODE, a shared effort on obesity biomarkers and endpoints.
| Organization | SCOPE 2027 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | |
Global pharmaceutical company focused on diabetes, obesity and rare blood and endocrine diseases. | Talk Tue Mar 2 11:30am–11:55am Talk Tue Mar 2 3:05pm–3:30pm Talk Tue Mar 2 3:30pm–3:55pm Panel Tue Mar 2 4:45pm–5:10pm Panel Tue Mar 2 4:45pm–5:10pm GLP1 Trials: Challenges and Solutions Trial design and delivery Talk Wed Mar 3 11:40am–12:05pm |
Instantly find 20 buyers from Novo Nordisk
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction